Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Sami Z. Daoud"'
Autor:
Kenneth R. Chapman, Robert A. Wise, Benjamin M. Scirica, Deepak L. Bhatt, Sami Z. Daoud, Dan Lythgoe, Esther Garcia Gil
Publikováno v:
Respiratory Research, Vol 22, Iss 1, Pp 1-10 (2021)
Abstract Background Beta-blocker therapies for cardiovascular comorbidities are often withheld in patients with chronic obstructive pulmonary disease (COPD) due to potential adverse effects on airway obstruction. We carried out a post hoc analysis to
Externí odkaz:
https://doaj.org/article/7add940580594b10a18f351c82fd2590
Autor:
Hong, Zhang, Sami Z, Daoud, Michael S, Gillen, Natalia, Calderon, Maria, Heijer, Eduard, Molins, Esther, Garcia-Gil, Hong, Chen, Qianqian, Li, Chengjiao, Liu, Yanhua, Ding
Publikováno v:
Drugs in R&D. 22:35-42
The aim of this study was to evaluate the pharmacokinetics, safety, and tolerability of aclidinium bromide/formoterol fumarate in patients from China with moderate-to-severe chronic obstructive pulmonary disease (COPD).In this open-label, repeat-dose
Autor:
Benjamin M. Scirica, Sami Z. Daoud, Kenneth R. Chapman, Esther García-Gil, Robert A. Wise, Dan Lythgoe
Publikováno v:
International Journal of Chronic Obstructive Pulmonary Disease
Robert A Wise,1 Kenneth R Chapman,2 Benjamin M Scirica,3,4 Sami Z Daoud,5 Dan Lythgoe,6 Esther Garcia-Gil7 1Medicine, Pulmonary and Critical Care, Johns Hopkins University School of Medicine, Baltimore, MD, USA; 2Department of Medicine, University of
Autor:
Benjamin M. Scirica, Robert A. Wise, Dan Lythgoe, Kenneth R. Chapman, Esther Garcia Gil, Sami Z. Daoud
Publikováno v:
Chest. 158:A1688-A1692
Autor:
Benjamin M. Scirica, Robert A. Wise, Sami Z. Daoud, Dan Lythgoe, Kenneth R. Chapman, Esther Garcia Gil
Publikováno v:
Chest. 158:A1734-A1738
Autor:
Benjamin M. Scirica, Kenneth R. Chapman, Sami Z. Daoud, Esther Garcia Gil, Dan Lythgoe, Robert A. Wise, Deepak L. Bhatt
Publikováno v:
Respiratory Research
Respiratory Research, Vol 22, Iss 1, Pp 1-10 (2021)
Respiratory Research, Vol 22, Iss 1, Pp 1-10 (2021)
Background Beta-blocker therapies for cardiovascular comorbidities are often withheld in patients with chronic obstructive pulmonary disease (COPD) due to potential adverse effects on airway obstruction. We carried out a post hoc analysis to determin
Autor:
Estel Plana, Sami Z. Daoud, Alejhandra Lei, Jaume Aguado, Elena Rivero-Ferrer, Cristina Rebordosa, Susana Perez-Gutthann, Nuria Saigi-Morgui, Annalisa Rubino
Publikováno v:
International Journal of Chronic Obstructive Pulmonary Disease
Cristina Rebordosa, 1 Estel Plana, 1 Annalisa Rubino, 2 Jaume Aguado, 1 Alejhandra Lei, 3 Sami Daoud, 4 Nuria Saigi-Morgui, 1 Susana Perez-Gutthann, 1 Elena Rivero-Ferrer 1 1RTI Health Solutions, Barcelona, Spain; 2Epidemiology, Respiratory and Immun
Autor:
Ferran Chuecos, Deepak L. Bhatt, Sami Z. Daoud, Esther Garcia Gil, Kenneth R. Chapman, Robert A. Wise, Benjamin M. Scirica
Publikováno v:
Advances in Therapy
Introduction Long-acting muscarinic antagonists (LAMAs), long-acting β2-agonists (LABAs), inhaled corticosteroids (ICS), and their combinations, are recommended for the treatment of chronic obstructive pulmonary disease (COPD). This study aimed to d
Autor:
Cristina Rebordosa, Anna Julia Witzleb, Nina Sahlertz Kristiansen, Susana Perez-Gutthann, Sami Z. Daoud, Estel Plana, Anton Pottegård, Elena Rivero-Ferrer, Tania Schink, Jaume Aguado, Morten Olesen, Annalisa Rubino, Alejhandra Lei, Nuria Saigi
Publikováno v:
Epidemiology.
Background: Use of aclidinium bromide (AB) and aclidinium/formoterol (AB/FF) in the real world is not fully characterized in Europe. Aim: To describe characteristics of new users of AB, AB/FF, and other COPD medications in the United Kingdom (UK), De
Autor:
Benjamin M. Scirica, Sami Z. Daoud, Kenneth R. Chapman, Esther Garcia Gil, Robert A. Wise, Dan Lythgoe
Publikováno v:
Chest. 156:A154-A156